Piramal Critical Care (PCC), a global leader in critical care medicines have acquired the EU, UK, Norway and South Africa commercialization rights and will sell market and distribute Neoatricon® in these countries. About BrePco Biopharma Limited: Ireland-based BPCO develops products for the unique needs of paediatric patients. The development of Neoatricon® was part funded by the …






